Cardiometabolic therapies
Cardiometabolic therapies has been studied in 2 papers since 2026: none in people yet, 2 reviews; 2 in the past year. No study of it in people or animals has been published yet. The newest paper, Oct 2, 2026: “PAD as a Marker of Systemic Atherosclerosis: A Comprehensive Review of Residual Risk and Contemporary Strategies for MACE and MALE Reduction”.
2 papers study it2 findingsUpdated
1 new paper in 30 daysSee all 2 papers on cardiometabolic therapies
At a glance
The findings reach people, from one lab or study. 1 lab in 3 countries.
None of its findings points the other way.
Humans: a single group. Cells, worms or flies and mice: nothing yet.
- 1 lab in 3 countries
What did studies of cardiometabolic therapies find?
2Studies of cardiometabolic therapies measured 2 outcomes: exercise capacity and heart failure outcomes.
Latest
2 papers in 12 monthsCureus
Diabetes, Adiposity, and Functional Phenotypes in HFpEF: A Systematic Review of Recent Treatment-Response Evidence
Systematic review of studies in peopleInterventions